In addition, enhanced expressions of P53 and PTEN promote the expression levels of caspase 9 in human ESCs, but inhibit AKT phosphorylation and tumor growth, demonstrating that the PTEN-P53 signaling pathway governs cell cycle exit in tumors [11]. This evidence concerns the gene TP53 and neoplasm.